poisar

Stocks · News reference

Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday

BenzingaAvi Kapoor

Nasdaq: NYAX rose 13.9% on Tuesday after announcing acquisition of IPS Group Inc. for $350 million. Other big gainers include CAPR, RZLV, CRML, and MAIR.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncDelveinsight

    NSCLC Treatment Landscape Shifts as ESMO 2026 Spotlights MET, KRAS, and TROP2 Advances, Says DelveInsight

    The non-small cell lung cancer market is shifting toward precision, biomarker-guided treatment sequencing. ESMO 2026 presented Phase III data showing savolitinib plus osimertinib improved survival in MET-altered EGFR-mutated NSCLC, divarasib outperformed approved KRAS G12C inhibitors, and TROP2-directed ADCs demonstrated durable gains. The 7MM NSCLC market is projected to double from USD 33 billion in 2025 to USD 67 billion by 2036, driven by expanded screening, biomarker-driven therapies, and label expansions into earlier-stage disease.

  2. The Motley FoolErin Kennedy

    Applied Materials vs. Marvell Technology: Which Tech Stock Is a Better Buy for 2027?

    The article compares two semiconductor infrastructure companies: Applied Materials, which manufactures chipmaking equipment, and Marvell Technology, which designs data center networking chips. While Marvell shows faster revenue growth (30.6% vs 21.4%), Applied Materials is recommended as the safer choice due to lower valuation multiples and reduced risk from Marvell's pending $115 billion acquisition of Lumentum Holdings.